Skip to main content

Lantheus Appoints Vivian Yao as Chief Human Resources Officer

Written by Customer Service on . Posted in Public Companies.

Vivian Yao

Vivian Yao, Lantheus Chief Human Resources Officer

Vivian Yao, Lantheus Chief Human Resources Officer

NORTH BILLERICA, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced the appointment of Vivian Yao to its Executive Team as Lantheus’ Chief Human Resources Officer. Ms. Yao will report directly to Lantheus’ President and Chief Executive Officer, Mary Anne Heino. In this role, Ms. Yao will oversee all aspects of Lantheus’ employee and workplace experience, including ensuring best-in-class talent processes, people operations, total rewards, organization effectiveness and next-generation HR capability.

“We are very excited to have Vivian join our team as we continue to grow our Company,” said Mary Anne Heino, President and CEO of Lantheus. “At Lantheus, we know our greatest asset is our employees and the flexibility of the current environment gives us an opportunity to reimagine what we can achieve together. With Vivian’s strong expertise in developing and promoting a culture of innovation across several complex global businesses, I am confident in her ability to lead us in living our values and motivating our employees to strive to be their best, so that we can continue to exceed expectations for customers and patients alike.”

“It is a privilege to join Lantheus, an organization that has taken on the important purpose to find, fight and follow serious medical conditions,” said Ms. Yao. “I look forward to working alongside Lantheus’ management team and our employees to develop and execute an effective, long-term foundation to attract new talent and support the continued growth and development of our people.”

Ms. Yao has more than 25 years of experience in Human Resources. Most recently Ms. Yao was the Vice President of Human Resources at Jabil’s EMS Division, where she was accountable for more than 100,000 employees globally. Prior to Jabil, she held Human Resource executive roles of increasing responsibility at Johnson & Johnson for Ethicon, Global Surgery, Global Medical Devices and One J&J China over the course of five years. In addition, Ms. Yao spent 11 years at General Electric in various global Human Resources roles of increasing accountabilities. She has a BA in International Business from China Foreign Affairs College and an MBA from the University of Michigan.

About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; PYLARIFY®, a PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate cancer; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com. 

Safe Harbor for Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” as defined under U.S. federal securities laws. Forward-looking statements may be identified by their use of terms such as build, can, confident, continue, develop, execute, grow, look forward, will and other similar terms. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to materially differ from those described in the forward-looking statements. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements are discussed in our filings with the Securities and Exchange Commission (including those described in the Risk Factors section in our Annual Reports on Form 10-K and our Quarterly Reports on Form 10-Q).

Contacts:
Mark Kinarney
Senior Director, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Director, Corporate Communications
646-975-2533
media@lantheus.com

Social Networks:
Website: https://www.lantheus.com/
LinkedIn: https://www.linkedin.com/company/lantheus/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/734c73ba-5852-4ca4-b364-3a38d2b908fd

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.